Paul Hartmann AG (FRA:PHH2) 5-Year EBITDA Growth Rate : -4.90% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Paul Hartmann AG 5-Year EBITDA Growth Rate?

Paul Hartmann AG's EBITDA per Share for the six months ended in Dec. 2023 was €31.79.

During the past 12 months, Paul Hartmann AG's average EBITDA Per Share Growth Rate was 0.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -18.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -4.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Paul Hartmann AG was 14.30% per year. The lowest was -18.50% per year. And the median was 2.20% per year.

Competitive Comparison of Paul Hartmann AG's 5-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paul Hartmann AG's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Paul Hartmann AG's 5-Year EBITDA Growth Rate falls into.

Paul Hartmann AG 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Paul Hartmann AG (FRA:PHH2) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Paul Hartmann AG 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Paul Hartmann AG's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Paul Hartmann AG (FRA:PHH2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paul Hartmann AG (FRA:PHH2) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

PHH2:Germany

Address

Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522

Website

http://www.hartmann.info

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.

Executives

Eduard Schleicher	Supervisory Board
Britta Fünfstück	Board of Directors

Paul Hartmann AG (FRA:PHH2) Headlines

No Headlines